The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
News|Articles|September 27, 2004
APhA to consumers: Know your pharmacist
Consumers aren't making the most of their relationship with their pharmacist.
Advertisement
Advertisement
Related to this article
The approval extends the medication to a younger pediatric population, marking the first FDA-approved treatment for children with this immunodeficiency.
Advertisement
Advertisement
Trending on Drug Topics
1
Nicotine Pouches Create Opportunity for Pharmacist Counseling
2
Worth a Shot: How ACIP Changes Might Impact Vaccine Access, Coverage
3
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
4
FDA Approves Finerenone for Chronic Kidney Disease With Type 1 Diabetes
5